TP53 Mutations Linked to Poor Prognosis in DLBCL
In the realm of hematological malignancies, diffuse large B-cell lymphoma (DLBCL) represents a formidable challenge due to its heterogeneous nature ...
In the realm of hematological malignancies, diffuse large B-cell lymphoma (DLBCL) represents a formidable challenge due to its heterogeneous nature ...
In a groundbreaking development, researchers have unveiled a novel and robust methodology for gene-specific variant classification that could significantly enhance ...
In a groundbreaking study poised to reshape the future of cancer therapeutics, researchers have unveiled a novel approach to reactivating ...
A groundbreaking advance in cancer genomics has emerged from the ultradeep sequencing of normal human tissues, revealing a natural saturation ...
The gene TP53, often referred to as the “guardian of the genome,” has long fascinated scientists because of its critical ...
In the ongoing battle against cancer, researchers have made significant strides in developing targeted therapies that can improve treatment outcomes ...
A new groundbreaking study has emerged from researchers at the Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins University School ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine